Equitable Holdings’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-10,634
Closed -$185K 1159
2023
Q3
$185K Buy
10,634
+429
+4% +$8.95K ﹤0.01% 1013
2023
Q2
$212K Buy
10,205
+1,572
+18% +$34.2K ﹤0.01% 968
2023
Q1
$203K Buy
+8,633
New +$232K ﹤0.01% 918

Other funds holding OGN

Equitable Holdings's OGN Position: Q4 2023 in Review

Equitable Holdings sold out of Organon & Co (OGN) in Q4 2023, closing a stake of 10,634 shares — an estimated $185K sold.

Equitable Holdings first reported a position in OGN in Q1 2023 and held it in 3 quarters. The position peaked at $212K in Q2 2023. 719 funds tracked by Wall St. Rank hold OGN as of Q4 2023.

  • Equitable Holdings reported no remaining Organon & Co position as of Q4 2023 after selling out during the quarter.
  • Equitable Holdings sold 10,634 Organon & Co shares in Q4 2023, an estimated $185K.
  • Equitable Holdings first reported a position in Organon & Co in Q1 2023 and held it in 3 quarters.
  • Equitable Holdings's Organon & Co position peaked at $212K in Q2 2023.
  • 719 funds tracked by Wall St. Rank held Organon & Co as of Q4 2023.

Based on Equitable Holdings's 13F filing for Q4 2023, filed 13 Feb 2024.